Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement

J Crit Care. 2021 Dec:66:187-188. doi: 10.1016/j.jcrc.2021.07.011. Epub 2021 Jul 27.

Authors

Thomas Köhler¹, Elke Schwier², Dietrich Henzler², Claas Eickmeyer²

Affiliations

¹ Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany. Electronic address: Thomas.Koehler@ruhr-uni-bochum.de.
² Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany.

No abstract available

Keywords: COVID-19; ECMO; Hemoadsorption; Interleukin-6.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Cytokines
Extracorporeal Membrane Oxygenation*
Hemoperfusion*
Humans
SARS-CoV-2

Substances

Cytokines